|
Ms. Carol Karp is Senior Vice President for Regulatory Affairs, Quality, and Drug Safety at CV Therapeutics. She has over 25 years of experience in regulatory affairs, project management, compliance, and quality assurance in the pharmaceutical industry. Before joining CV Therapeutics, she was Vice President of Scientific Affairs at PowderJect Technologies. Ms. Karp has held previous positions as a corporate officer at VIVUS, Inc. and established the regulatory affairs function at Cygnus, Inc., a transdermal drug delivery company, where she was the project leader for EVRA®, the first oral contraceptive patch co-developed with Johnson & Johnson. Ms. Karp began her career in regulatory affairs at Janssen Pharmaceutica, a Johnson & Johnson company, where she managed the approval process for several new drug applications.
Ms. Karp received her bachelor's degree in biology from the University of Rochester and pursued graduate studies at New York University. | 